Therapeutic Targeting of SIRT3 for Aggressive and Refractory Lymphomas Grant

Overview

date/time interval

March 2, 2023 - February 28, 2027

awarded by

National Cancer Institute

administered by

Medicine-Hematology and Medical Oncology

sponsor award ID

1 R01 CA270243-01A1

Affiliation

contributor

Krumsiek, Jan Co-Investigator 2023 - 2027
Li, Meng Principal Investigator 2023 - 2027
Melnick, Ari M. Key Personnel 2023 - 2027